Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Surgical axilla dissection. Technical standard or obsolete method?].

T Bachleitner-Hofmann1, M Gnant

  • 1Universitätsklinik für Allgemeinchirurgie, Wien. thomas.bachleitner-hofmann@akh-wien.ac.at

Zentralblatt Fur Chirurgie
|December 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concordance between clinician-reported toxicities and patient-reported symptom severity in early-stage breast cancer: an analysis of the randomized phase III PANTHER trial.

ESMO open·2026
Same author

Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13).

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

The impact of analysis methodology details on invasive breast cancer-free survival in randomized clinical trials.

ESMO open·2025
Same author

Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109).

ESMO open·2025
Same author

Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Axillary lymph node biopsy is crucial for breast cancer prognosis and treatment. Sentinel lymph node biopsy shows promise as a less invasive staging method with comparable accuracy to standard axillary dissection.

Area of Science:

  • Oncology
  • Surgical Pathology

Context:

  • Axillary lymph node status is a critical prognostic factor in breast carcinoma.
  • Standard axillary dissection is the established method for staging, offering high sensitivity and specificity.

Purpose:

  • To evaluate the efficacy of axillary staging methods in breast cancer.
  • To compare the accuracy and implications of standard axillary dissection with alternative and emerging techniques.

Summary:

  • Standard axillary dissection provides reliable prognostic information and improves local tumor control, reducing recurrence risk.
  • Less invasive methods like palpation, ultrasonography, CT-scan, immunoscintigraphy, and PET-scan have limitations in standardization or accuracy.
  • Sentinel lymph node biopsy emerges as a promising alternative, demonstrating sensitivity and specificity comparable to standard axillary dissection.

Related Experiment Videos

Impact:

  • Sentinel lymph node biopsy has the potential to optimize clinical management for breast cancer patients, particularly in early stages.
  • Accurate axillary staging influences therapeutic decisions and improves patient outcomes.